AD Working Group Proposes New Alzheimer's Definition to Include Protein Biomarkers
October 15, 2010
AD Working Group Proposes New Alzheimer's Definition to Include Protein Biomarkers
The proposed definition incorporates findings from recent work on the use of protein biomarkers in cerebrospinal fluid to develop diagnostic and prognostic assays for the disease. If adopted by the community, the new definition could have significant regulatory and drug-development implications.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Protein Biomarkers for Alzheimer's Predicted to Represent Cumulative $9B Market Over Next Decade
June 3, 2011 / ProteoMonitor - New Alzheimer's Guidelines Call for Use of Protein Biomarkers in Clinical Research
April 22, 2011 / ProteoMonitor - Initial Analysis of ADNI Plasma Proteome Data Suggests Possible Protein Signatures for Alzheimer's
December 10, 2010 / ProteoMonitor - ADNI Researchers and Industry Partners Developing Proteomic Profiles to Track Alzheimer's Disease
June 11, 2010 / ProteoMonitor - Penn Researchers ID Acetylated Tau as Potential Protein Biomarker for Alzheimer's, Related Disorders
April 8, 2011 / ProteoMonitor